Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.680
+0.330 (9.85%)
Oct 24, 2025, 3:44 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 98.84 million as of October 24, 2025. Its market cap has decreased by -68.83% in one year.
Market Cap
98.84M
Enterprise Value
151.51M
Revenue
45.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.68
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 98.84M, a decrease of -85.21%. That is a compound annual growth rate of -33.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 89.98M | 93.81% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | 668.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.39B |
| Nordhealth AS | 2.74B |
| ArcticZymes Technologies ASA | 1.58B |
| Photocure ASA | 1.38B |
| Thor Medical ASA | 1.24B |
| Vistin Pharma ASA | 962.28M |
| Omda AS | 953.61M |
| Gentian Diagnostics ASA | 857.48M |